JF Healthcare, a Nanchang, China-based medical diagnostic startup is the first organization in the world to beat Stanford University radiologists in a competition designed by the Stanford Machine Learning group to compare the capability of artificial intelligence (AI) to human experts in interpreting chest x-rays.Standard Chest X-ray Diagnostic Competition ResultsThe AI team from JF Healthcare recently achieved an average AUC score (a measure of diagnostic accuracy) of 0.926 and is currently
Read More
Lung Cancer
Belong.Life Raises $14M to Expand AI-Powered Social Network for Cancer Patients
Belong.Life, creators of the "Belong - Beating Cancer Together" mobile app, the world's largest social network and navigator app for cancer patients, caregivers and healthcare professionals announced it has raised $14M in Series B funding led by IQVI. The Series B round also included participation from The Group Ventures and other existing investors.Founded in 2015 by noted entrepreneurs Eliran Malki, Irad Deutsch and Ohad Rubin after each lost relatives to cancer, Belong - Beating Cancer
Read More
Mayo Clinic to Develop New Diagnostic Test Using Patients’ Breath to Detect Lung Cancer
Mayo Clinic Laboratories is teaming up with Breath Diagnostics to develop new clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The first collaboration will focus on a diagnostic test that detects lung cancer using patients' exhaled breath. Benefits of BiomarkersBiomarkers are measurable substances that help in predicting the severity of a disease or infection. Examples of a biomarker include an individual's pulse
Read More
AdoRx Therapeutics, J&J Team Up to Develop Novel Lung Cancer Therapeutics
AdoRx Therapeutics, a UK based drug discovery company, and Johnson & Johnson are teaming up to develop novel therapeutics for the treatment of lung cancer. As part of the strategic collaboration, AdoRx has granted an exclusive option to research, develop and commercialize novel antagonists within the AdoRx portfolio, and the groups will collaborate on drug discovery and preclinical development activities. AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer-based on
Read More
Montefiore Health to Create AI-Based Screening Tool to Help Doctors Identify Lung Failure
Funded by a $1.2 million Agency for Healthcare Research and Quality grant, Montefiore Health System is building a new artificial intelligence (AI) screening tool to help doctors better identify and treat acute respiratory distress syndrome (ARDS), a deadly, but under-recognized, form of lung failure. Acute respiratory distress syndrome (ARDS) is a rapidly progressive disease occurring in critically ill patients.The main complication in ARDS is that fluid leaks into the lungs making breathing
Read More
Augusta University Health & Philips Partner to Streamline Lung Cancer Diagnosis with Hybrid Operating Room
Today, Philips and Augusta University Health announced a long-term partnership to expedite the diagnosis and treatment of lung cancer with a hybrid operating room. Knowing early detection is key to a patient’s survival, the hybrid operating room combines three techniques into a single appointment with a multidisciplinary team, eliminating the delays of multiple clinical visits. The hybrid operating room pilot has shown promising results, such as:- Prior to this, it could take up to six weeks
Read More
